New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2013
12:16 EDTHAIN, SRPT, SWKS, TPXOptions with increasing implied volatility: SRPT TPX SWKS HAIN
News For SRPT;TPX;SWKS;HAIN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
13:24 EDTSRPTLiberia, U.S. begin ZMapp ebola trial
In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases launched a clinical trial to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The study may be expanded to test ZMapp against other treatments which may also include the following: Tekmira siRNA from Tekmira Pharmaceuticals (TKMR), Favipiravir from Toyama Chemical, BCX4430 from BioCryst (BCRX), and AVI-7537 from Sarepta (SRPT). The trial is expected to conclude in December 2016.
09:58 EDTSRPTOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 500.com (WBAI) downgraded to Hold from Buy at Deutsche Bank... Akorn (AKRX) downgraded to Hold after share rally at Needham... Allscripts (MDRX) downgraded to Market Perform from Outperform at Leerink... Bank of America (BAC) downgraded to Neutral from Buy at UBS... Bill Barrett (BBG) downgraded to Hold from Buy at KLR Group... CA Technologies (CA) downgraded to Underperform from Neutral at Credit Suisse... CBOE Holdings (CBOE) downgraded at BofA/Merrill... CONE Midstream (CNNX) downgraded to Sector Perform from Outperform at RBC Capital... Calamos (CLMS) downgraded to Underperform from Neutral at Credit Suisse... Crane (CR) downgraded to Market Perform from Outperform at FBR Capital... Dick's Sporting (DKS) downgraded to Equal Weight from Overweight at Barclays... EnerNOC (ENOC) downgraded to Buy from Strong Buy at Needham... Hercules Offshore (HERO) downgraded to Sell from Buy at Deutsche Bank... Insulet (PODD) downgraded at Oppenheimer... Intelsat (I) downgraded to Underperform from Neutral at Credit Suisse... Laredo Petroleum (LPI) downgraded to Market Perform from Outperform at Northland... Mavenir Systems (MVNR) downgraded to Equal Weight from Overweight at Morgan Stanley... Memorial Production (MEMP) downgraded to Underperform from Perform at Oppenheimer... Mobileye (MBLY) downgraded to Neutral from Buy at Dougherty... NTELOS (NTLS) downgraded to Market Perform from Outperform at Wells Fargo... Ocwen (OCN) downgraded to Sell from Neutral at Compass Point... Pegasystems (PEGA) downgraded to Neutral from Buy at Merriman... Performant Financial (PFMT) downgraded to Neutral from Buy at Compass Point... Pharmacyclics (PCYC) downgraded to Neutral from Buy at Goldman... Potbelly (PBPB) downgraded to Underweight from Overweight at Piper Jaffray... SYNNEX (SNX) downgraded to Hold from Buy at Stifel... Safe Bulkers (SB) downgraded at Credit Suisse... Sarepta (SRPT) downgraded to Market Perform from Outperform at Cowen... Seadrill Partners (SDLP) downgraded to Sector Perform from Outperform at RBC Capital... Spirit Realty (SRC) downgraded at RBC Capital... Transocean (RIG) downgraded to Sector Perform from Outperform at Iberia... UIL Holdings (UIL) downgraded to Neutral from Outperform at RW Baird... WCI Communities (WCIC) downgraded to Neutral from Buy at Citigroup... Walter Investment (WAC) downgraded to Neutral from Outperform at Credit Suisse.
09:11 EDTSRPTSarepta downgraded to Market Perform from Outperform at Cowen
Subscribe for More Information
February 26, 2015
07:15 EDTSRPTSarepta reports Q4 adjusted EPS (94c), consensus (82c)
Subscribe for More Information
February 20, 2015
15:31 EDTHAINHain Celestial acquires health and beauty products maker Belvedere
Hain Celestial announced the acquisition of Belvedere International, a health and beauty care products maker. "We are excited by the acquisition of the Live Clean brand, which expands our presence in the personal care category and complements our Avalon Organics, Alba Botanica and JASON brands that we sell into Canada. This acquisition increases the scale of our Canadian operations to over $150M in net sales and provides us with opportunities for sales expansion and cost efficiencies as we leverage our existing infrastructure in Canada and our manufacturing and research and development expertise in personal care," said Hain CEO Irwin Simon. The Live Clean brand is the leading natural hair care and baby care brand in Canada. In calendar year 2014 Belvedere had approximately $25M in net sales and is expected to be accretive to Hain Celestial's earnings in fiscal year 2016.
February 19, 2015
10:32 EDTTPXHigh option volume stocks:
Subscribe for More Information
February 18, 2015
08:20 EDTTPXTempur Sealy says strategic priorities include expanding margins
Says strategic priorities include accretive acquisitions of licensees, JVs, expanding distribution, expanding margins.
08:19 EDTTPXTempur Sealy sees FY15 adjusted EPS growth 12%-27%
Sees FY15 adjusted EPS growth 12%-27% and net sales growth 5.5%-8.5%, as adjusted for FX. Not adjusted for FX, sees FY15 adjusted EPS growth 2%-17%, net sales growth 2%-5%.
08:17 EDTTPXTempur Sealy says targeting 15% annual base adjusted EPS growth 2015-2018
Says targeting 6% annual base sales growth 2015-2018. Targeting 50bps annual base operating margin improvement 2015-2018. Comments from Investor Day presentation slides.
February 17, 2015
17:14 EDTSRPTPoint72 lowers passive stake in Sarepta to 4.4% from 5.2%
Subscribe for More Information
13:36 EDTTPXTempur Sealy says 'disappointed' in H Partners going public
Subscribe for More Information
12:50 EDTSRPTOn The Fly: Midday Wrap
Subscribe for More Information
10:00 EDTSRPTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:20 EDTSRPTOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Vipshop Holdings (VIPS), up 10.9%... VASCO Data Security (VDSI), up 7.1%... Waste Management (WM), up 3.7%. ALSO HIGHER: Starwood Hotels (HOT), up 1.9% after appointing Adam Aron as interim CEO... Sarepta Therapeutics (SRPT), up 7.3% after being upgraded at BofA/Merrill... Navidea Biopharmaceuticals (NAVB), up 7.5% after publishing results of phase 3 Lymphoseek trial... Campus Crest (CCG), up 7.7% after announcing that it will explore strategic alternatives as well as Clinton Group and Campus Evolution proxy contest... Cyren (CYRN), up 7.1% following distribution agreement with ALSO Deutschland. DOWN AFTER EARNINGS: Helix Energy (HLX), down 13.3%... Walter Energy (WLT), down 10.1%. ALSO LOWER: Celsus Therapeutics (CLTX), down 82.3% after MRX-6 Cream 2% Phase II trial did not meet primary endpoint... Vascular Biogenics (VBLT), down 53.2% after reporting that VB-201 Phase 2 studies did not meet primary endpoints and removal of FDA partial clinical hold on VB-111... Vanguard Natural Resources (VNR), down 7.1% after reporting preliminary fourth quarter results.
07:43 EDTSRPTSarepta upgraded at BofA/Merrill
As previously reported, BofA/Merrill upgraded Sarepta to Buy from Neutral. The firm has increased confidence that eleplirsen will be approved for treating boys with DMD. Price target raised to $21 from $19.
07:42 EDTTPXTempur Sealy shareholder H Partners demands leadership, board changes
Subscribe for More Information
07:15 EDTHAINConsumer Analyst Group of New York (CAGNY) to hold a conference
Subscribe for More Information
06:36 EDTTPXH Partners to demand CEO change at Tempur Sealy, WSJ says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use